They believe that by focusing on and addressing their underlying psychiatric comorbidities, like depression or anxiety, they are essentially introducing a ‘hidden’ solution that will surreptitiously infiltrate and resolve their substance use issues. First, it fails to acknowledge how underlying factors can contribute to the development of both conditions, assuming a simplistic cause-and-effect relationship (e.g., suggesting that an individual’s alcohol use ‘caused’ their depression or anxiety). This underscores the idea that substance use often serves a role as a form of self-medication, with individuals using substances for specific reasons and rationales. The co-occurrence of SUDs and psychiatric conditions is characterized by the intricate interplay between the psychological, biological, and social underpinnings of these dual conditions 10. From a diagnostic standpoint, the co-occurrence of SUDs and psychiatric conditions introduces distinct challenges, particularly when arriving at a diagnosis involving two or more comorbid disorders. For instance, stimulant use disorders, such as those involving methamphetamine, can manifest symptoms of psychosis, including auditory and visual hallucinations, paranoid delusions, disorganized thinking, and disorganized behavior.
Psychotherapeutic Approaches
For instance, approximately one in five individuals with an eating disorder will develop an SUD at some point in their lifetime, with one in ten currently meeting SUD criteria 5. Likewise, evidence suggests a disproportionate impact of opioid use disorder (OUD) among individuals with schizophrenia, who are less likely to receive opioid agonist therapy (OAT) and tend to have a poorer prognosis 6. Additionally, comorbidity with cannabis use disorder (CUD) is notably higher among individuals with bipolar disorder 7.
- Often, this process poses a formidable challenge that cannot be definitively resolved during the initial assessment.
- Someone who has been through trauma or has experienced chronic stress might use substances like drugs and alcohol as a form of self-medication.
- Download, read, and order free NIMH brochures and fact sheets about mental disorders and related topics.
- Studies show traumatic, extremely stressful experiences like abuse, violence, neglect, or the death of a loved one make a person more vulnerable to developing a substance use disorder.
- However, SSRIs are still recommended as the first-line medication because of their safety, tolerability, and lower risk of interaction with alcohol or other drugs (42, 43).
Other websites
Moreover, it is essential to differentiate between the common co-occurrence of these conditions and the notion that SSRIs directly ‘cause’ alcohol use. This review aims to delve into recent research findings, evidence-based guidelines, and emerging trends within the field. By synthesizing this wealth of information, this review seeks to construct a valuable resource for clinicians, researchers, and policymakers, assisting them in navigating the intricate terrain of comorbidity in substance use and psychiatric disorders.
This review describes the epidemiology and treatment of co-occurring disorders, with a focus on major depressive disorder, anxiety disorders, and attention-deficit hyperactivity disorder. Substance use may make diagnosis of the underlying psychiatric condition difficult, and a period of abstinence may be necessary. Findings from efficacy studies of medications used to treat co-occurring disorders are reviewed, as are results of preliminary studies of newer treatments, such as topiramate, ketamine, noninvasive brain stimulation, and deep brain stimulation.
However, this hypothesis also lacks an evidence base and may be influenced by bias, especially in cases where patients seek stimulants for secondary gain. This divergence between the amelioration of psychiatric symptoms and the continued engagement in alcohol use provides valuable insights for both the patient and the clinicians. It suggests that alcohol use may represent a separate, concurrent issue rather than being exclusively attributable to an underlying psychiatric illness. This nuanced perspective reevaluates SUDs as distinct illnesses that do not always have a direct causal link to another psychiatric disorder. Instead, it underscores their concurrent nature, recognizing that these disorders can coexist independently, and one may not necessarily be a direct consequence of the other.
Can a person have more than one substance use disorder?
Learn about NIMH priority areas for research and funding that have the potential to improve mental health care over the short, medium, and long term. Over 40 research groups conduct basic neuroscience research and clinical investigations of mental illnesses, brain function, and behavior at the NIH campus in Bethesda, Maryland. Hence, rather than imposing a blanket restriction on the use of SSRIs for individuals with dual disorders, a judicious and case-by-case evaluation is recommended. In complex cases where diagnostic ambiguity exists, referring the individual to a psychiatrist with expertise in addiction can be particularly beneficial.
This task is prone to various forms of bias, especially in the absence of collateral information or observation. The recent CADDRA guidelines recommend against relying solely on the mental status examination to support or refute an ADHD diagnosis, potentially limiting the diagnosis to self-report. However, this approach raises concerns, as it may open the door to individuals seeking secondary gain, given that the gold-standard treatment for moderate-to-severe ADHD involves the prescription of psychostimulant medication. As previously discussed, there exists a substantial overlap between alcohol use disorders (AUDs) and mood/anxiety disorders, a common presentation encountered by psychiatrists. Yet, the approach to treating individuals with these concurrent disorders is intricate, primarily due to several challenging factors.
- It encompasses a diverse array of approaches, including pharmacological, psychotherapeutic, and integrated strategies, with the overarching aim of providing profound insights and guidance to those at the forefront of addiction and psychiatry 4.
- A very promising line of research has focused on developing novel treatment approaches for co-occurring disorders.
- Also, people’s recollections of when drug use or addiction started may be imperfect, making it difficult to determine whether the substance use or mental health issues came first.
- Anxiety disorders are among the most common class of psychiatric disorders in the United States and across the globe, frequently co-occurring with substance use disorders and causing greater functional impairment, increased disability, and worsening outcomes than for either disorder alone (58–60).
- In this ancient story, the Greeks used a massive wooden horse as a deceptive strategy to gain entry into the city of Troy.
- This underscores the idea that substance use often serves a role as a form of self-medication, with individuals using substances for specific reasons and rationales.
The initiative also supports solutions to mitigate suicide risk and expand suicide prevention efforts for people who misuse opioids, have an opioid use disorder, or experience acute or chronic pain. The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is an ambitious, high-priority effort across the National Institutes of Health (NIH) to speed scientific solutions to stem the opioid public health crisis and better manage chronic pain conditions. NIMH plays a major role in the initiative by leading research examining how to treat people affected by both opioid use disorder and mental illnesses. However, it is crucial to acknowledge that, for many individuals, SSRIs are a valuable treatment option. It is important to recognize that untreated depression and anxiety are significant risk factors for alcohol use disorder.
Integrated care models, which combine SUD and mental health treatment, have demonstrated efficacy in improving outcomes for this complex population 18. These models acknowledge that individuals with dual diagnoses often face overlapping challenges that cannot be effectively addressed in isolation 19. Studies have shown that individuals receiving integrated care experience enhanced treatment engagement, reduced substance use, improved mental health, and an overall better quality of life 20,21. Substance use disorder is a highly prevalent condition, leading to significant morbidity, mortality, and burden on the health care system. Yet management remains a challenge among clinicians and has been a source of confusion and considerable controversy.
Part 3. The Connection between Substance Use Disorders and HIV
For instance, if an individual newly diagnosed with ADHD experiences a positive response to ADHD medication, that response is sometimes used to validate the diagnosis. However, this practice lacks an evidence-based foundation, as healthy volunteers (those without ADHD) also report improved concentration and focus when taking stimulants. Stimulants promote attention and concentration in individuals both with and without ADHD, making this response an unreliable confirmation of the diagnosis. In essence, the approach should be individualized, considering the unique circumstances and needs of each person. This approach not only recognizes the substance use and co-occurring mental disorders national institute of mental health nimh complex interplay between these disorders but also emphasizes the importance of tailored interventions that promote the overall well-being of individuals with dual diagnoses. NIDA plays a leading role in the National Institutes of Health HEAL (Helping to End Addiction Long-term®) Initiative, an effort to develop new scientific solutions to the national opioid addiction and overdose public health crisis and to improve pain management.
This review has shed light on the intricate interplay between psychological, biological, and social factors that define comorbidity. It underscores the importance of individualized care, embracing integrated treatment models, and recognizing the limitations of pharmacological interventions in isolation. Furthermore, the “Trojan Horse” concept has highlighted the need for nuanced approaches that consider the multifaceted nature of concurrent disorders. Studies show traumatic, extremely stressful experiences like abuse, violence, neglect, or the death of a loved one make a person more vulnerable to developing a substance use disorder.
How does trauma affect a person’s brain and body?
It raises doubts about their safety and efficacy, as the two forms of addiction may not necessarily share the same biological underpinnings. While concerns have arisen regarding the over-diagnosis of many psychiatric conditions, diagnosing ADHD in adults without a pre-existing childhood or developmentally-oriented diagnosis is a controversial area that has received increasing attention in recent years. For example, when an adult seeks diagnostic evaluation, clinicians must determine if the symptoms of inattention, hyperactivity, and/or impulsivity had a developmental onset (e.g., before the age of 12).
Of interest, although anxiety disorders are more common among women, men with anxiety disorders appear to be more likely than women with these disorders to have a comorbid substance use disorder (12). NIMH leads a research program that seeks to optimize the delivery of services for people with opioid use disorders, mental disorders, and suicide risk. The program supports a range of innovative services and intervention research to develop, optimize, and test approaches to improve the delivery of care for this vulnerable population. The NIH HEAL Initiative supports a range of programs to develop new or improved prevention and treatment strategies for opioid addiction and co-occurring mental disorders.
